NutraLife Biosciences, Inc. (OTCQB: NLBS) Receives Contract to Provide Its Technologies and Delivery System...
Coconut Creek, FL - (ACN Newswire) - via NEWMEDIAWIRE -- NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) announces it has signed an agreement with Orlando...
NutraFuels, Inc Tests Confirm High Quality Proprietary Ultra Shear Technology Platform
Coconut Creek, FL - (ACN Newswire) - via NEWMEDIAWIRE -- NutraFuels, Inc (NTFU) and Pressure BioSciences, Inc (PBI), in a joint venture, announce that analytical tests on...
NutraFuels, Inc. Founds NutraDerma Technologies and Acquires Patented All-Natural Skin Patch For Deet-Free Mosquito...
Coconut Creek, FL - (ACN Newswire) - via NEWMEDIAWIRE -- NutraFuels, Inc. (NTFU), soon to be NutraLife BioScience, Inc. ("NutraFuels" or the "Company") has acquired a patent...
Creso Pharma Targets Multi-Billion Dollar Pet Industry — CFN Media
SEATTLE, WA - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis...
How to get the most fuel out of microalgae?
Direct electrolysis has mixed results for extracting fuel sources from microalgae.
Selangor, Malaysia - (ACN Newswire) - Researchers are investigating ways to improve biodiesel production by using electrical...
Huakang Biomedical Holdings Company Limited Announces the Offer Price and Allotment Results of the...
Received Positive Response in the Public Offer
HONG KONG - (ACN Newswire) - Huakang Biomedical Holdings Company Limited ("Huakang Biomed" or the "Company", together with its subsidiaries, the...
Huakang Biomedical Holdings Company Limited Announces Its Share Offering
HONG KONG - (ACN Newswire) - Huakang Biomedical Holdings Company Limited ("Huakang Biomed" or the "Company", together with its subsidiaries, the "Group", stock code: 8622),...
Looking for ways to measure tumour aggression
Tests show an association between how aggressive a tumour is and the levels of sugar and inflammatory proteins in the blood.
Selangor, Malaysia - (ACN Newswire) - Researchers...
Sino Biopharmaceutical Announces 2018 Third Quarterly Results
Profit Attributable to the Group Increased by Approximately 29.9% to Approximately RMB 2,247,477,000
HONG KONG - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the...
OIC Medicines Authorities committed to cooperating toward Safe, Efficacious and Standardized Medicines and Vaccine...
- First Meeting of OIC NMRAs concludes in the Jakarta Declaration
JAKARTA - (ACN Newswire) - The heads of National Medicines Authorities (NMRA) from the Organization of Islamic...
Innovent HK IPO gains wide support from international investors; Spearheads in cancer treatment breakthroughs
HONG KONG - (ACN Newswire) - Chinese biologic drug developer Innovent Biologics (Innovent) becomes the 4th pre-revenue biotech firm to list in Hong Kong yesterday. The seven-year-old...
Innovent Biologics Gets Listed Today; Long-term Bullish Performance Anticipated
HONG KONG - (ACN Newswire) - Innovent Biologics , a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong, with trading officially...
Innovent Biologics Gets Listed Today; Long-term Bullish Performance Anticipated
HONG KONG - (ACN Newswire) - Innovent Biologics , a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong, with trading officially commencing today....
Microbiome – The Next Frontier in Medicine
HONG KONG - (ACN Newswire) - Earlier this year the Hong Kong Exchange updated its listing rules to include pre-revenue biotech stocks for the first...
Ascletis Successfully Listed on the Main Board of HKEX
HONG KONG - (ACN Newswire) - Recently, following the official implementation of the revised listing rules by the Hong Kong Stock Exchange (HKEX), the Hong Kong capital...
Ascletis’ NDA for Its All-oral HCV Treatment Accepted by CFDA
Hangzhou and Shaoxing, China - (ACN Newswire) - Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir...
Ascletis-developed Ganovo Acquired Extraordinary Achievement
Ganovo Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association
HONG KONG - (ACN Newswire) - Ascletis announced on...
